Tintut Y, Demer L L
Department of Medicine, UCLA School of Medicine, Los Angeles, California 90095-1679, USA.
Curr Opin Lipidol. 2001 Oct;12(5):555-60. doi: 10.1097/00041433-200110000-00012.
Calcification presents important clinical implications in cardiovascular diseases, especially in coronary arteries. Epidemiological evidence has shown the coexistence of vascular calcification with both atherosclerosis and osteoporosis, and increasing evidence has shown the role of hyperlipidemia and atherogenic phospholipids in vascular calcification. The etiology of vascular calcification is also increasingly recognized as an active process. Vascular calcification initiates with matrix vesicle formation and mineralization following a process similar to that in bone. In addition, many bone regulatory factors have been shown to be present in calcified atherosclerotic lesions. In this review, we focus on the new developments emerging during the past year in regulation of vascular calcification. Regulatory factors include matrix GLA protein, the phosphate cotransporter Pit-1, a calcium-sensing receptor related factor, osteoprotegerin, leptin, bisphosphonates and oxidized lipids. Some of these, including oxidized lipids, osteoprotegerin, and bisphosphonates, appear to regulate mineralization in both bone and vasculature and may account for the co-existence of osteoporosis and atherosclerotic calcification that is independent of age.
钙化在心血管疾病尤其是冠状动脉疾病中具有重要的临床意义。流行病学证据表明血管钙化与动脉粥样硬化和骨质疏松症并存,并且越来越多的证据显示高脂血症和致动脉粥样硬化磷脂在血管钙化中所起的作用。血管钙化的病因也日益被认为是一个活跃的过程。血管钙化始于基质小泡的形成和矿化,其过程类似于骨骼中的情况。此外,许多骨调节因子已被证明存在于钙化的动脉粥样硬化病变中。在本综述中,我们重点关注过去一年中血管钙化调节方面出现的新进展。调节因子包括基质GLA蛋白、磷酸盐共转运体Pit-1、一种钙敏感受体相关因子、骨保护素、瘦素、双膦酸盐和氧化脂质。其中一些因子,包括氧化脂质、骨保护素和双膦酸盐,似乎在骨骼和血管系统中均调节矿化,并且可能解释了与年龄无关的骨质疏松症和动脉粥样硬化钙化并存的现象。